Quick Takeaways
- Andrew Lo has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,825,377.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Andrew Lo
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Andrew Lo is at least $4,825,377 dollars as of 19 Nov 2025. Andrew Lo is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $4.29M. Andrew Lo is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $539.7K.
- Signature
- /s/ Will Solis, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Andrew Lo and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: BridgeBio Pharma, Inc. ($4,285,707).
- Past-year value change for that position: -$10,169,562.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Andrew Lo
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Director | $4,285,707 | -$10,169,562 | -70% | 17 Nov 2025 |
| ROIV | Roivant Sciences Ltd. | Director | $539,670 | 15 Sep 2022 | ||
| ABCL | AbCellera Biologics Inc. | Director | 12 Jun 2025 |
Insider Transactions Reported by Andrew Lo:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.